These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
391 related items for PubMed ID: 11862518
1. Experimental research photodynamic effects in perifocal, oedematous brain tissue. Goetz C, Hasan A, Stummer W, Heimann A, Kempski O. Acta Neurochir (Wien); 2002 Feb; 144(2):173-9; discussion 179. PubMed ID: 11862518 [Abstract] [Full Text] [Related]
2. Photodynamic therapy within edematous brain tissue: considerations on sensitizer dose and time point of laser irradiation. Stummer W, Hassan A, Kempski O, Goetz C. J Photochem Photobiol B; 1996 Nov; 36(2):179-81. PubMed ID: 9002256 [Abstract] [Full Text] [Related]
3. Subclinical photodynamic therapy treatment modifies the brain microenvironment and promotes glioma growth. deCarvalho AC, Zhang X, Roberts C, Jiang F, Kalkanis SN, Hong X, Lu M, Chopp M. Glia; 2007 Aug 01; 55(10):1053-60. PubMed ID: 17551928 [Abstract] [Full Text] [Related]
4. The effect of photodynamic therapy on a retinoblastoma-like tumour. An experimental in vitro and in vivo study on the potential use of photodynamic therapy in the treatment of retinoblastoma. Winther JB. Acta Ophthalmol Suppl (1985); 1990 Aug 01; (197):1-37. PubMed ID: 2176429 [Abstract] [Full Text] [Related]
5. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors. Bellnier DA, Gollnick SO, Camacho SH, Greco WR, Cheney RT. Cancer Res; 2003 Nov 15; 63(22):7584-90. PubMed ID: 14633671 [Abstract] [Full Text] [Related]
6. Sensitivity of 9L gliosarcomas to photodynamic therapy. Chopp M, Dereski MO, Madigan L, Jiang F, Logie B. Radiat Res; 1996 Oct 15; 146(4):461-5. PubMed ID: 8927718 [Abstract] [Full Text] [Related]
7. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow. Chan WS, Brasseur N, La Madeleine C, van Lier JE. Anticancer Res; 1996 Oct 15; 16(4A):1887-92. PubMed ID: 8712717 [Abstract] [Full Text] [Related]
8. Oedema formation in experimental photo-irradiation therapy of brain tumours using 5-ALA. Ito S, Rachinger W, Stepp H, Reulen HJ, Stummer W. Acta Neurochir (Wien); 2005 Jan 15; 147(1):57-65; discussion 65. PubMed ID: 15565479 [Abstract] [Full Text] [Related]
9. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model. Engbrecht BW, Menon C, Kachur AV, Hahn SM, Fraker DL. Cancer Res; 1999 Sep 01; 59(17):4334-42. PubMed ID: 10485481 [Abstract] [Full Text] [Related]
10. [Photodynamic therapy mediated with 5-aminolevulinic acid for C6 glioma spheroids]. Kamoshima Y, Terasaka S, Iwasaki Y. Hokkaido Igaku Zasshi; 2008 May 01; 83(3):167-73. PubMed ID: 18546870 [Abstract] [Full Text] [Related]
11. Comparison of the in vivo photodynamic threshold dose for photofrin, mono- and tetrasulfonated aluminum phthalocyanine using a rat liver model. Farrell TJ, Wilson BC, Patterson MS, Olivo MC. Photochem Photobiol; 1998 Sep 01; 68(3):394-9. PubMed ID: 9747595 [Abstract] [Full Text] [Related]
12. Photoirradiation therapy of experimental malignant glioma with 5-aminolevulinic acid. Olzowy B, Hundt CS, Stocker S, Bise K, Reulen HJ, Stummer W. J Neurosurg; 2002 Oct 01; 97(4):970-6. PubMed ID: 12405389 [Abstract] [Full Text] [Related]
13. Experimental evaluation of possible side effects of intra-operative photodynamic therapy on rabbit blood vessels and nerves. Kübler AC, Stenzel W, Rühling M, Meul B, Fischer JH. Lasers Surg Med; 2003 Oct 01; 33(4):247-55. PubMed ID: 14571449 [Abstract] [Full Text] [Related]
14. Using white light during photodynamic therapy: visualization only or treatment? Mordon S, Maunoury V. Eur J Gastroenterol Hepatol; 2006 Jul 01; 18(7):765-71. PubMed ID: 16772834 [Abstract] [Full Text] [Related]
15. Atorvastatin reduces functional deficits caused by photodynamic therapy in rats. Zheng X, Chopp M, Lu Y, Jiang J, Zhao D, Ding C, Yang H, Zhang L, Jiang F. Int J Oncol; 2011 Nov 01; 39(5):1133-41. PubMed ID: 21850369 [Abstract] [Full Text] [Related]
16. Optimal light dose and drug dosage in the photodynamic treatment using PHOTOCYANINE. Xue J, Li C, Liu H, Wei J, Chen N, Huang J. Photodiagnosis Photodyn Ther; 2011 Sep 01; 8(3):267-74. PubMed ID: 21864801 [Abstract] [Full Text] [Related]
17. Intrathoracic organ injury associated with photodynamic therapy. Pelton JJ, Kowalyshyn MJ, Keller SM. J Thorac Cardiovasc Surg; 1992 Jun 01; 103(6):1218-23. PubMed ID: 1534592 [Abstract] [Full Text] [Related]
18. A phase II trial of intraperitoneal photodynamic therapy for patients with peritoneal carcinomatosis and sarcomatosis. Hahn SM, Fraker DL, Mick R, Metz J, Busch TM, Smith D, Zhu T, Rodriguez C, Dimofte A, Spitz F, Putt M, Rubin SC, Menon C, Wang HW, Shin D, Yodh A, Glatstein E. Clin Cancer Res; 2006 Apr 15; 12(8):2517-25. PubMed ID: 16638861 [Abstract] [Full Text] [Related]
19. Combination of surgical resection and photodynamic therapy of 9L gliosarcoma in the nude rat. Zhang X, Jiang F, Kalkanis SN, Yang H, Zhang Z, Katakowski M, Hong X, Zheng X, Chopp M. Photochem Photobiol; 2006 Apr 15; 82(6):1704-11. PubMed ID: 17007560 [Abstract] [Full Text] [Related]
20. Intraoperative photodynamic therapy of the chest cavity in malignant pleural mesothelioma bearing rats. Krueger T, Pan Y, Tran N, Altermatt HJ, Opitz I, Ris HB. Lasers Surg Med; 2005 Oct 15; 37(4):271-7. PubMed ID: 16245295 [Abstract] [Full Text] [Related] Page: [Next] [New Search]